University of Nebraska
Continuous glucose monitoring (CGM) has demonstrated improved outcomes in both type 1 and type 2 diabetes populations in comparison to traditional methods; however, these devices have not been well studied in underserved adult patients (e.g., low-income, uninsured) who may face additional barriers to monitoring. Furthermore, there is limited data exploring long-term (3- to 6- month) health care team-based management of these devices in the primary care setting. The purpose of this study is to further understand the benefits and barriers associated with CGM use in underserved populations with type 2 diabetes and improve their overall diabetes care.
Continuous glucose monitoring (CGM) has demonstrated improved outcomes in both type 1 and type 2 diabetes populations in comparison to traditional methods; however, these devices have not been well studied in underserved adult patients (e.g., low-income, uninsured) who may face additional barriers to monitoring. Furthermore, there is limited data exploring long-term (3- to 6- month) health care team-based management of these devices in the primary care setting. This study will evaluate the perceived and experienced benefits and barriers of continuous glucose monitor (CGM) and traditional gluco…
Inclusion Criteria: * Type 2 diabetes * A1c \>9% at recruitment * On/initiating insulin or on two or more diabetes medications Exclusion Criteria: * Current use of an insulin pump * On dialysis * Pregnant * Implanted medical device (e.g., pace-maker, defibrillator) * Intellectual or physical disabilities that may interfere with ability to properly use the Continuous Glucose Monitor (CGM) * Able to read English
A Freestyle Libre 2 continuous glucose monitor (CGM) will be provided in the experimental arm of this study for 6 months.
A traditional glucometer device will be assigned in the active comparitor arm of this study for 6 months.
Arctuva estimate
Actual pay is set by the research site.
Verify or correct the compensation shown for this listing.